Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LNG Energy Announces Signing of Hydrocarbon Productive Participation Contracts (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
InMed Pharmaceuticals Inc
INM
Healthcare
Cannabis
InMed Pharmaceuticals Inc. is a clinical-stage pharmaceutical company. The Company is engaged in developing a pipeline of prescription-based products, including rare cannabinoids and cannabinoid analogs, targeting the treatment of diseases with high unmet medical needs, as well as developing proprietary manufacturing technologies to produce rare cannabinoids for sale in the health and wellness...
industry. Its segments include InMed Pharmaceuticals and BayMedica. The InMed Pharmaceuticals segment is engaged in research and development of cannabinoid-based pharmaceutical products. The BayMedica segment is focused on developing manufacturing technologies to produce rare cannabinoids for sale in the health and wellness industry. Its two product candidates include INM-755 and INM-088. INM-755 is developed as a topical skin cream formulation containing cannabinol (CBN) for the treatment of symptoms related to Epidermolysis Bullosa (EB). INM-088 is used for the treatment of glaucoma.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:INM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Aug 02, 2022 10:48pm
Market Manipulation
An example of what can happen. Even the company doesn't know why the stock is up so much: https://finance.yahoo.com/quote/HKD/
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Jul 28, 2022 11:20pm
D9 THCV Study (Harrison Tweet)
A study indicated that 9-tetrahydrocannabinol and cannabinol inhibit lung cancer cell growth 9-Tetrahydrocannabinol and cannabinol significantly inhibited cell proliferation, increased the number of
...more
C.RVV Announces Type C Meeting Request Granted by FDA for Clinical Study
posted Apr 24, 2024 9:00am by
Revive Therapeutics Ltd.
-
|
Currently, the Company is exploring the use of Bucillamine as a potential treatment for long COVID. The Company is advancing the clinical development of Bucillamine by leveraging the published research and data from its previous Phase 3 clinical trial (the “Study”) and is finalizing the regulatory and clinical package that includes a proposed clinical study for long COVID to present to the FDA ...read more
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Jul 25, 2022 4:04pm
Research by Ailment
https://www.cb1cap.com/researchailment
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Jul 25, 2022 7:43am
Patent Granted and Updates
https://www.globenewswire.com/news-release/2022/07/25/2484970/36215/en/InMed-Announces-Update-on-Phase-2-Clinical-Trial-Investigating-INM-755-Cannabinol-Cream-for-Epidermolysis-Bullosa.html
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jul 25, 2022 7:30am
New Press Release - InMed Announces Update on Phase 2 Clinical Trial Investigating INM-755 Cannabinol Cream for Epidermolysis Bullosa
Phase 2 clinical trial recently expanded to include adolescents following independent review of early safety dataFirst adolescent patient with EB enrolled into clinical trial and completed treatment International patent granted for the use of cannabinol for the treatment of epidermolysis bullosa ...
read article.
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Jul 24, 2022 8:36am
List of Cannabinoids
https://www.newphaseblends.com/list-of-cannabinoids/
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jul 18, 2022 7:30am
New Press Release - InMed Announces Appointment of Chief Operating Officer
VANCOUVER, British Columbia, July 18, 2022 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today announces Michael Woudenberg has been appointed Chief...
read article.
(2)
•••
JakeVegas
X
View Profile
View Bullboard History
Comment by
JakeVegas
on Jul 15, 2022 9:25am
RE:Volume Spike InMed On the Move
Yes it spiked to a new year low. Great analysis on this dumpster fire
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Jul 14, 2022 12:36pm
Volume Spike InMed On the Move
$INM InMed +27% and seems to be on the move today & volume coming in as well!
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Jul 14, 2022 12:34pm
Volume Spike along with SP
Just noticed a big spike in volume. Apparently, there is huge demand for D9 THCV. https://finance.yahoo.com/quote/INM/
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Jul 13, 2022 11:45am
D9 THCV Sale
https://lulacbd.shop/products/d9-thcv-isolate
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jul 12, 2022 11:33pm
New Press Release - InMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Compliance
VANCOUVER, British Columbia, July 12, 2022 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a research, development, manufacturing corporation specializing in the commercialization of rare cannabinoids, announces that, as previously disclosed pursuant to a...
read article.
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Jul 09, 2022 9:20am
Pharma Blue Sky
Skip to 45:00 https://youtu.be/ngaeP7dUtp8
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Jul 07, 2022 10:32pm
Pharma Biotech M&As Have Started
https://www.reuters.com/markets/deals/merck-advanced-talks-buy-seagen-40-billion-deal-wsj-2022-07-07/
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Jul 05, 2022 10:49pm
Growth Over the Next 10 years
https://youtu.be/AssQAYmOo0I
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Stage Set for Creation of a Leading Intermediate Gold Producer
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study
Discover a Green Resources Stock Scoring Record Quarterly Growth